160 related articles for article (PubMed ID: 27223089)
1. FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Huang Z; Li J; Du S; Tang Y; Huang L; Xiao L; Tong P
Oncotarget; 2016 Jun; 7(26):39872-39884. PubMed ID: 27223089
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of FKBP14 on human cervical cancer cells.
Sun LY; Tao JZ; Yan B; Lin JS
Mol Med Rep; 2017 Oct; 16(4):4265-4272. PubMed ID: 28731139
[TBL] [Abstract][Full Text] [Related]
3. TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Chen Y; Guo Y; Yang H; Shi G; Xu G; Shi J; Yin N; Chen D
Oncotarget; 2015 Sep; 6(27):23708-19. PubMed ID: 26247633
[TBL] [Abstract][Full Text] [Related]
4. MiR-361 inhibits osteosarcoma cell lines invasion and proliferation by targeting FKBP14.
Wang K; Qi XJ; Liu HZ; Su H
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):79-86. PubMed ID: 29364473
[TBL] [Abstract][Full Text] [Related]
5. RNAi-mediated silencing of AQP1 expression inhibited the proliferation, invasion and tumorigenesis of osteosarcoma cells.
Wu Z; Li S; Liu J; Shi Y; Wang J; Chen D; Luo L; Qian Y; Huang X; Wang H
Cancer Biol Ther; 2015; 16(9):1332-40. PubMed ID: 26176849
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma.
Cai X; Liu Y; Yang W; Xia Y; Yang C; Yang S; Liu X
J Orthop Res; 2016 Jun; 34(6):932-41. PubMed ID: 26575981
[TBL] [Abstract][Full Text] [Related]
7. Saurolactam Inhibits Proliferation, Migration, and Invasion of Human Osteosarcoma Cells.
Li Z; Liu H; Li B; Zhang Y; Piao C
Cell Biochem Biophys; 2015 Jul; 72(3):719-26. PubMed ID: 25627547
[TBL] [Abstract][Full Text] [Related]
8. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
9. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
10. RNAi-Mediated Downregulation of FKBP14 Suppresses the Growth of Human Ovarian Cancer Cells.
Lu M; Miao Y; Qi L; Bai M; Zhang J; Feng Y
Oncol Res; 2016; 23(6):267-74. PubMed ID: 27131312
[TBL] [Abstract][Full Text] [Related]
11. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.
Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z
Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962
[TBL] [Abstract][Full Text] [Related]
12. Effects of baicalein on apoptosis, cell cycle arrest, migration and invasion of osteosarcoma cells.
Zhang Y; Song L; Cai L; Wei R; Hu H; Jin W
Food Chem Toxicol; 2013 Mar; 53():325-33. PubMed ID: 23266503
[TBL] [Abstract][Full Text] [Related]
13. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma.
Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101
[TBL] [Abstract][Full Text] [Related]
14. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
[TBL] [Abstract][Full Text] [Related]
15. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
[TBL] [Abstract][Full Text] [Related]
16. GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.
Kim M; Jung JY; Choi S; Lee H; Morales LD; Koh JT; Kim SH; Choi YD; Choi C; Slaga TJ; Kim WJ; Kim DJ
Autophagy; 2017 Jan; 13(1):149-168. PubMed ID: 27754745
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
18. DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo.
Chen D; Hu C; Wen G; Yang Q; Zhang C; Yang H
Calcif Tissue Int; 2018 Jan; 102(1):117-127. PubMed ID: 29038881
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
20. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
